Valesca P. Retèl
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 36
- Breast Cancer Treatment Studies 28
- Oncology top 5%
- Global Cancer Incidence and Screening 13
- Cancer Immunotherapy and Biomarkers 11
- Otorhinolaryngology top 5%
- Economics and Econometrics top 5%
- Health Systems, Economic Evaluations, Quality of Life 34
- Economic and Financial Impacts of Cancer 13
-
- Lung Cancer Treatments and Mutations 14
-
- BRCA gene mutations in cancer 16
- Co-authors
- Wim H. van HartenSabine C. LinnLotte SteutenManuela JooreMichael KnauerEmiel J. RutgersMaarten J. IJzermanJelle Wesseling
- Partner nations
- NetherlandsUnited StatesAustralia
In The Last Decade
Valesca P. Retèl
125 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 132
- Cancer Research 631
- Oncology 542
- Otorhinolaryngology 80
- Economics and Econometrics 317
- Pulmonary and Respiratory Medicine 323
Countries citing papers authored by Valesca P. Retèl
This map shows the geographic impact of Valesca P. Retèl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valesca P. Retèl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valesca P. Retèl more than expected).
Fields of papers citing papers by Valesca P. Retèl
This network shows the impact of papers produced by Valesca P. Retèl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valesca P. Retèl. The network helps show where Valesca P. Retèl may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Valesca P. Retèl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 3 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 11 | |
| 8 | 2024 | 0 | |
| 9 | 2024 | 2 | |
| 10 | 2023 | 4 | |
| 11 | 2023 | 2 | |
| 12 | 2023 | 3 | |
| 13 | 2023 | 13 | |
| 14 | 2023 | 2 | |
| 15 | 2023 | 1 | |
| 16 | 2022 | 18 | |
| 17 | 2022 | 5 | |
| 18 | 2021 | 23 | |
| 19 | 2019 | 20 | |
| 20 | Establishing cost-effectiveness of genetic targeting of cancer therapies | 2008 | 0 |
About Valesca P. Retèl
Valesca P. Retèl is a scholar working on Cancer Research, Oncology and Otorhinolaryngology, having authored 137 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (36 papers), Health Systems, Economic Evaluations, Quality of Life (34 papers), Breast Cancer Treatment Studies (28 papers), BRCA gene mutations in cancer (16 papers), Lung Cancer Treatments and Mutations (14 papers), Economic and Financial Impacts of Cancer (13 papers), Global Cancer Incidence and Screening (13 papers) and Cancer Immunotherapy and Biomarkers (11 papers). The work is most often cited by research in Cancer Research (631 citations), Oncology (542 citations) and Otorhinolaryngology (80 citations). Valesca P. Retèl has collaborated with scholars based in Netherlands, United States and Australia. Frequent co-authors include Wim H. van Harten, Sabine C. Linn, Lotte Steuten, Manuela Joore, Michael Knauer, Emiel J. Rutgers, Maarten J. IJzerman, Jelle Wesseling, Peter Loskill and Frans J. M. Hilgers. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.